1[1]Chowdhury TA, Dyer PH, Kumar S, et al. Genetic determinants of diabetic nephropathy. J Clinical Science, 1999,96: 221.
2[2]Krolewski AS. Genetics of diabetic nephropathy: Evidence for major and minor gene effects. J Kidney International, 1999,55:1582.
3[3]Craven P, Derubertis FR, Melhem M. Nitric oxide in diabetic nephropathy. Kidney Iht, 1997,52: s46.
4[4]Marsden PA, Heng HHQ, Scherer SWS, et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. The Journal of Biological Chemistry, 1993,268:17478.
5[5]Shimasaki Y, Yasue HY, Yoshimura M, et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J AM Coll Cardiol, 1998,31:1506.
6[6]Cai H,Wang X,Colagiuri S,et al. A common Glu298→Asp(894G→T)mutation at exon 7 of the endothelial nitric oxide synthase gene and vascular complications in type 2 diabetes. Diabetes Care, 1998,21:2195.
7[7]Weekers L, Hadjadj S, Belloum R, et al. Lack of contribution of two endothelial nitric oxide synthase (eNOS) gene polymorphism to diabetic nephropathy in type 1 diabetes. Diabetologia, 1999supplement, 42 : A266.
8[8]Tsukada T, Yokoyama K, Arai T,et al. Evidence of association of the eNOS gene polymorphism with plasma NO metabolite levels in humans[J]. Biochem Biophs Res Com, 1998, 245:190.
9[9]Zanchi A, Moczulski DK, Hanna LS, et al. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int, 2000,57: 405.
10[10].Imperatore G, Hanson RL, Pettitt DJ, et al. Sib-pair linkage analysis for susceptibility genes for microvascular complications among pima indians with type 2 diabetes. Diabetes, 1998,47:821.
